Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.11 USD | -5.60% | -6.66% | -53.66% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Low profitability weakens the company.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-53.66% | 380M | C | ||
+3.53% | 2,894B | C+ | ||
+3.05% | 80.94B | B | ||
+1.20% | 75.01B | B+ | ||
-16.29% | 52.08B | B+ | ||
+27.96% | 48.93B | D+ | ||
-27.56% | 44.85B | B- | ||
+15.13% | 40.49B | D+ | ||
+56.02% | 36.29B | D+ | ||
-11.27% | 24.36B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CRNC Stock
- Ratings Cerence Inc.